Community pharmacists in Saudi Arabia provide brief consultations and frequently recommend OTC melatonin for insomnia, but often fail to provide safety counseling or non-pharmacological advice.
In a cross-sectional study using simulated patient visits across Saudi Arabia, 251 pharmacy consultations were observed. The median consultation duration was only 1.5 minutes, 64.5% of pharmacists recommended melatonin, but safety information was provided in only 4.9% of visits and non-pharmacological advice in 9.6%.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Community pharmacists in Saudi Arabia provide brief consultations and frequently recommend OTC melatonin for insomnia, but often fail to provide safety counseling or non-pharmacological advice. The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Community pharmacists in Saudi Arabia provide brief consultations and frequently recommend OTC melatonin for insomnia, but often fail to provide safety counseling or non-pharmacological advice.
This conclusion is most relevant to: Community pharmacists in urban, suburban, and rural areas of Saudi Arabia (251 simulated visits).
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Evaluating community pharmacists' practices in managing insomnia in Saudi Arabia: a cross-sectional study using simulated patient visits. (Frontiers in public health, 2026) —
How It Works
The proposed biological pathway:
- ▸Pharmacist encounters simulated patient with insomnia complaint
- ▸Pharmacist conducts brief consultation (median 1.5 min)
- ▸Pharmacist recommends OTC melatonin (64.5%)
- ▸Pharmacist rarely provides safety information (4.9%) or non-pharmacological advice (9.6%)
Who Might Benefit
Evidence fit by population:
- ▸Community pharmacists in urban, suburban, and rural areas of Saudi Arabia (251 simulated visits)
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Cross-sectional design limits causal inference
- ▸Simulated patient methodology may not fully capture real-world pharmacist behavior
References
- 1.Algarni M, Alghamdi S, Barakat BM, Alshammari TM, Alzahrani A, Alzahrani A, Sumayli H, Al-Qahtani SA, Mantargi MJS. “Evaluating community pharmacists' practices in managing insomnia in Saudi Arabia: a cross-sectional study using simulated patient visits..” Frontiers in public health, 2026. PMID: 42395279 DOI: 10.3389/fpubh.2026.1792148